Publisher Full Text
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System.Trends Neurosci. 2020 06; 43(6):355-357.TN
Abstract
Emerging evidence indicates that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of coronavirus disease 2019 (COVID-19), can cause neurological complications. We provide a brief overview of these recent observations and discuss some of their possible implications. In particular, given the global dimension of the current pandemic, we highlight the need to consider the possible long-term impact of COVID-19, potentially including neurological and neurodegenerative disorders.
Links
MeSH
Pub Type(s)
Journal Article
Review
Language
eng
PubMed ID
32359765
Citation
De Felice, Fernanda G., et al. "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System." Trends in Neurosciences, vol. 43, no. 6, 2020, pp. 355-357.
De Felice FG, Tovar-Moll F, Moll J, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System. Trends Neurosci. 2020;43(6):355-357.
De Felice, F. G., Tovar-Moll, F., Moll, J., Munoz, D. P., & Ferreira, S. T. (2020). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System. Trends in Neurosciences, 43(6), 355-357. https://doi.org/10.1016/j.tins.2020.04.004
De Felice FG, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System. Trends Neurosci. 2020;43(6):355-357. PubMed PMID: 32359765.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System.
AU - De Felice,Fernanda G,
AU - Tovar-Moll,Fernanda,
AU - Moll,Jorge,
AU - Munoz,Douglas P,
AU - Ferreira,Sergio T,
Y1 - 2020/04/21/
PY - 2020/04/12/received
PY - 2020/04/14/accepted
PY - 2020/5/4/pubmed
PY - 2020/6/6/medline
PY - 2020/5/4/entrez
KW - COVID-19
KW - Parkinson’s disease
KW - anosmia
KW - encephalitis
KW - neurodegenerative diseases
KW - neurological alterations
SP - 355
EP - 357
JF - Trends in neurosciences
JO - Trends Neurosci
VL - 43
IS - 6
N2 - Emerging evidence indicates that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of coronavirus disease 2019 (COVID-19), can cause neurological complications. We provide a brief overview of these recent observations and discuss some of their possible implications. In particular, given the global dimension of the current pandemic, we highlight the need to consider the possible long-term impact of COVID-19, potentially including neurological and neurodegenerative disorders.
SN - 1878-108X
UR - https://www.unboundmedicine.com/medline/citation/32359765/full_citation
L2 - https://linkinghub.elsevier.com/retrieve/pii/S0166-2236(20)30091-6
DB - PRIME
DP - Unbound Medicine
ER -